Is Intuitive Surgical a healthcare company?
Table of Contents
Is Intuitive Surgical a healthcare company?
Intuitive Surgical (NASDAQ:ISRG) is a medical device company that is best known for its minimally invasive robotic surgery system, da Vinci.
Is Intuitive Surgical overvalued?
Intuitive Surgical appears to be overvalued by 24% at the moment, based on my discounted cash flow valuation. The stock is currently priced at US$302 on the market compared to my intrinsic value of $243.24.
How many times has Intuitive Surgical stock split?
According to our Intuitive Surgical stock split history records, Intuitive Surgical has had 2 splits.
Why is Intuitive Surgical stock dropping?
Why? Because management gave out weak guidance on the Q1 conference call. According to the executive team, patients are still delaying elective surgeries (which Intuitive Surgical specializes in) around the globe because of the COVID-19 pandemic.
Is Intuitive Surgical a buy or sell?
Intuitive Surgical has received a consensus rating of Buy. The company’s average rating score is 2.78, and is based on 12 buy ratings, 5 hold ratings, and no sell ratings.
Where is Intuitive Surgical based?
Sunnyvale, California
Our headquarters are in Sunnyvale, California, along with manufacturing, research, and training operations.
When was the last time Intuitive Surgical stock split?
The first split for ISRG took place on October 06, 2017. This was a 3 for 1 split, meaning for each share of ISRG owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split. ISRG’s second split took place on October 05, 2021.
Is daVinci surgery safe?
A study of a large administrative database looking at nearly 10,000 women having hysterectomy for benign disease found no differences in complications. In appropriately trained hands the da Vinci surgical system is safe.
Is Intuitive Surgical stock a buy?
Analysts, on average, see it as having an upside of 15% in the next 12 months. Considering that Intuitive is trading more than 20% below its 52-week high of $369.69 per share, it looks like the right time to buy this healthcare stock. Intuitive has the potential to outperform the market in the longer run.
